Consistently, our previous work supports the selective biodistribution of the nanotoxins to the high CXCR4-overexpressing tumor tissue, avoiding the accumulation and off-target toxicity in normal organs with low or negligible CXCR4 expression. Here, CXCR4 is linked to neoplasm.